ProImmune’s mission is to be your partner of choice for understanding and managing adaptive immune responses. Our unique solutions for preclinical and clinical immunology research include a comprehensive antigen characterization platform, and products and services for tracking antigen-specific immune responses with state-of-the-art ELISpot and flow cytometry techniques.

We are committed to helping you take your studies to success through product innovation, responsive service and focused application support, saving you time and money and reducing risk. Our Story

Our Clients

Latest News

ProImmune launches new ProMix™ immunodominant peptide pools, containing pre-mixed key epitopes from across a whole protein or pathogen.

Registrations open for 3rd Mastering Immunogenicity conference in Boston, September 16-17 2013. Early bird rates apply!

> ProImmune publishes T cell epitope identification by mass spectrometry in Drug Discovery World.

> ProImmune publishes Immunogenicity risk management for commercial advantage in Drug Discovery Today.

> ProImmune launches ProStorm™, an in vitro cytokine release assay designed to indicate when a cytokine storm first infusion reaction may be a risk for a therapeutic.

> Customer testimonials

> Latest customer publications